Erectile Dysfunction
Gene therapy improves condition in rat study
Published in Gene Therapy Weekly, May 1st, 2003
Johns Hopkins University researchers suggest this may have potential for treatment of erectile dysfunction in humans.
"Increased superoxide anion (O2-) may contribute to vascular dysfunction in aging," T.J. Bivalacqua and colleagues said.
"In aged cavernosal tissue, lucigenin-enhanced chemiluminescence demonstrated a threefold increase in superoxide formation, and the oxidative fluorescent probe hydroethidine indicated higher superoxide levels throughout the aged penis. This increase in superoxide was...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2003-05-01)
More Articles from Gene Therapy Weekly
- Ischemic Heart Disease
IGF gene transfer protects cardiomyocytes from apoptosis, boosts angiogenesis - Vector Development
Intravenous negative-strand RNA viral vectors can be used for gene replacement - Gene Delivery
Method offers selective protection of internal restriction endonuclease sites - Stem Cell-Based Gene Therapy
HSCs from different sources have different transduction efficiencies - Transgenic Cell Therapy
Neovascularized organoid can deliver proteins in nonmyeloablated recipients - Adeno-Associated Virus Vectors
Study follows genetic fate of rAAV genomes in muscle - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
